Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Finding Diamonds in the Rough

While the markets were rocked at the end of January by the Wuhan coronavirus, the beginning of February has seen a return to the non-stop climb that began in last fall. Once we break things down by sector, however, the picture becomes murkier. The cannabis sector continues...
Omri Wallach | February 5, 2020 |

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Has the entire market been brought down by the COVID-19 coronavirus pandemic? Not exactly. While most sectors have been battered by the economic downturn brought by the outbreak, a few stocks have not only evaded the damage, they’ve benefited. As the ...
Omri Wallach | March 18, 2020 |

good natured Products: transforming bio-based technology into earth-friendly products

Welcome to the Market Herald, I’m Simon Druker and you’re watching the Top Line. good natured Products Inc. is focused on transforming bio-based technology into earth-friendly products, available across the food sector. The Vancouver-ba...
Simon Druker | April 17, 2023 |

Translate Bio and Sanofi Expand Partnership to Develop mRNA Vaccines

Translate Bio shares traded 45% higher reaching a new 52-week high after the company reported that it is expanding its collaboration with Sanofi Pasteur to develop mRNA vaccines across all infectious disease areas. Clinical-stage messenger RNA (mRNA) therapeutics c...
Streetwise Reports | June 24, 2020 |

Viela Bio Shares Trade Higher After Analyst Issues 'Buy' Recommendation

Shares of Viela Bio Inc. rose 20% after an analyst at H.C. Wainwright & Co. initiated coverage of the stock. This morning, shares of clinical-stage biotechnology firm Viela Bio Inc. (VIE:NASDAQ) , which is focused on pioneering treatments for autoimmune and...
Streetwise Reports | February 19, 2020 |

Cancer Fighter Sesen Bio Leaps 13% on FDA Decision

Shares of this biotech stock were up significantly at the close of trading on Tuesday, May 21, attributed to the announcement of some good news from the FDA. Sesen Bio Inc. (SESN:NASDAQ) announced in a press release early Tuesday morning that the U.S. Foo...
Streetwise Reports | May 22, 2019 |

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. Early this morning, gene therapy focused biopharmaceutical company IVERIC bio Inc. (I...
Streetwise Reports | October 29, 2019 |

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test

Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. Aytu BioScience Inc. (AYTU:NASDAQ) announced today...
Streetwise Reports | March 11, 2020 |

Coverage Initiated on 'Solid Platform Company' with Sanofi Partnership

The reasons why this biopharma makes a compelling investment are outlined in a ROTH Capital Partners report. In a June 18 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on Translate Bio (TBIO:NASDAQ) , in advan...
Streetwise Reports | June 27, 2019 |

Why Provention Bio Is in My Portfolio

Quite often when I write about companies I'm just about the only one doing so. It's in these situations that Tailwinds can add value by not only highlighting our investment thesis, but in educating investors about a company for which there is little to no publicly avail...
Streetwise Reports | August 26, 2019 |
1 2 3 4 5 6 7 8 9 10 ...